Editorials
-
PublishedMarch 6, 2022
Our View: Maine’s new surplus should fund mental health
State refund checks will help offset inflationary pressures on households, but higher prices are not our only problem.
-
PublishedMarch 6, 2022
Another View: Sen. Collins was right to oppose voting rights bills
Voter turnout shows that democracy is not dead, despite warnings from Democrats and the editorial board.
-
PublishedMarch 5, 2022
Another View: Long-overdue federal anti-lynching law finally appears headed for passage
The potential for unanimous approval in the Senate could send a strong message of zero tolerance for this form of domestic terrorism.
-
PublishedMarch 4, 2022
Our View: Whatever you call it, solitary confinement should be banned
There’s disagreement over how the practice is used, but by any name, isolation does more harm than good to people incarcerated in Maine.
-
PublishedMarch 3, 2022
Our View: Don’t wait to fix Maine’s indigent defense
A lawsuit alleges what many observers of our system for hiring lawyers for the poor have found: The system is broken.
-
PublishedMarch 2, 2022
Our View: End of school district mask mandates doesn’t signal end of COVID
Maine students and parents should continue to think of their most vulnerable community members.
-
PublishedMarch 1, 2022
Our View: ‘Standing with Ukraine’ means more than vodka boycott
Bipartisan unity, not a no-cost, symbolic gesture, is the way to put pressure on the regime in Russia.
-
PublishedFebruary 28, 2022
Another View: When the world faces this kind of crisis, national unity is paramount
The world needs America to stand up against Putin’s aggression in Ukraine.
-
PublishedFebruary 27, 2022
Our View: Maine should not miss chance to make utilities better
But a consumer-owned utility may remain the goal even as companies and regulators are put on notice that performance must improve.
-
PublishedFebruary 26, 2022
Another View: FDA should pull ineffective pregnancy drug until we know it works
The FDA determined that Makena, meant to prevent premature births, is not effective. Until the company presents strong evidence otherwise, take it off the market.
- ← Previous Page
- 1
- …
- 40
- 41
- 42
- 43
- 44
- …
- 693
- Next Page →